Cargando…
Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
An essential step for cancer vaccination is to break the immunosuppression and elicit a tumor-specific immunity. A major hurdle against cancer therapeutic vaccination is the insufficient immune stimulation of the cancer vaccines and lack of a safe and efficient adjuvant for human use. We discovered...
Autores principales: | Wu, Aihua, Chen, Yingzhi, Wang, Hairui, Chang, Ya, Zhang, Meng, Zhao, Pengfei, Tang, Yisi, Xu, Qin, Zhu, Zhuangzhi, Cao, Yang, Huang, Yongzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642616/ https://www.ncbi.nlm.nih.gov/pubmed/34900541 http://dx.doi.org/10.1016/j.apsb.2021.06.001 |
Ejemplares similares
-
Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
por: Zhao, Pengfei, et al.
Publicado: (2018) -
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery
por: Chen, Yingzhi, et al.
Publicado: (2017) -
Engineered Viruses as Vaccine Platforms
por: Folgori, Antonella, et al.
Publicado: (2012) -
The GB4.0 Platform, an All-In-One Tool for CRISPR/Cas-Based Multiplex Genome Engineering in Plants
por: Vazquez-Vilar, Marta, et al.
Publicado: (2021) -
Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor
por: Zhang, Meng, et al.
Publicado: (2023)